Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
0
Authors
Stephen Russell
38 more
Stephen Russell
•
Okan Elci
36 more
•
Albert Maguire
Published
July 14, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Internal Medicine
Ophthalmology
Pediatrics
Molecular Biology
Show all topics
DOI
10.1016/s0140-6736(17)31868-8
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Internal Medicine
Ophthalmology
Pediatrics
Molecular Biology
Show all topics
DOI
10.1016/s0140-6736(17)31868-8
Other Formats
PDF
